Medical News

RSS

Exposing pregnant women to chemotherapy does not affect the foetus

Professor Frederic Amant of the Katholieke Universiteit Leuven (K.U.Leuven) directs research into the treatment of cancer in pregnant women and the consequences of such treatment on foetal development. In her PhD dissertation on chemotherapy during pregnancy, Kristel Van Calsteren presents new scientific discoveries.

23 Oct 2009

RemedyMD set to deliver 100 specialized disease registry software

RemedyMD (www.RemedyMD.com), the leading provider of specialty applications for comparative effectiveness research, announced its intent to deliver 100 highly specialized patient, disease and clinical registries in the next 90 days.

23 Oct 2009

Wyle awarded an additional year on its Occupational Medicine and Occupational Health contract supporting NASA

Wyle has been awarded an additional year on its Occupational Medicine and Occupational Health contract supporting NASA with the extension bringing the five-year value of the contract to more than $54 million running through July 2011.

23 Oct 2009

Key tracking measures of public support for health care reform held steady in October

After falling over the summer then ticking upward in September, key tracking measures of public support for health care reform held steady in October with more Americans backing an overhaul of the U.S. health system than opposing it, according to the latest Kaiser Health Tracking Poll.

23 Oct 2009

AFGE praises Obama for signing Veterans Health Care Budget Reform and Transparency Act

The American Federation of Government Employees (AFGE), today, praised President Barack Obama for signing the Veterans Health Care Budget Reform and Transparency Act which will provide advance funding for the Department of Veterans Affairs.

23 Oct 2009

Quality of U.S. health care was virtually stagnant in 2008, says NCQA report

A report released today by the National Committee for Quality Assurance (NCQA) finds that the quality of U.S. health care was virtually stagnant in 2008, a disturbing slowdown after a decade of improvements. The across-the-board trend was seen in care provided to people with private insurance coverage as well as in Medicare and Medicaid.

23 Oct 2009

New technique developed to transform regular body cells into artificial stem cells

Scientists have overcome a key barrier to the clinical use of stem cells with a technique which transforms regular body cells into artificial stem cells without the need for introducing foreign genetic materials, which could be potentially harmful. The research, published in STEM CELLS, suggests that cells taken from a patient's eye can be "reprogrammed" to replace or restore cells lost to degenerative diseases.

23 Oct 2009

Boehringer Ingelheim receives European CHMP positive opinion for MICARDIS

Boehringer Ingelheim announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Evaluation Agency (EMEA) has issued a positive opinion for the approval of MICARDIS® (telmisartan) for the reduction of cardiovascular morbidity.

23 Oct 2009

Methyl-Seq and Ultra-Deep Resequencing applications from RainDance Technologies

RainDance Technologies, Inc., a leading provider of innovative microdroplet-based solutions for human health and disease research, announced today it will extend the capabilities of its Sequence Enrichment Solution by offering Methyl-Seq and Ultra-Deep Resequencing applications.

23 Oct 2009

Archexin has potential to target and treat multiple life-threatening cancers, finds new study

Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and central nervous system (CNS) therapeutics, today announced the results of an animal study that further demonstrates the company’s Phase II oncology drug, Archexin™, as having the potential to target and treat multiple life-threatening cancers.

23 Oct 2009

Verizon Foundation awards $10,000 grant to The Wellness Community of the East Bay

The Wellness Community of the East Bay has been awarded a $10,000 grant from the Verizon Foundation, the philanthropic arm of Verizon, to fund the use of technology to identify the best community-based psychological and social support and education strategies for cancer patients and their families.

23 Oct 2009

Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals start Phase 3 trial to evaluate Nexavar tablets

Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, Inc. today announced the companies have begun enrolling patients in an international Phase 3 trial to evaluate Nexavar® (sorafenib) tablets for the treatment of patients with radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer.

23 Oct 2009

Study shows appropriate use of CRRT improves AKI patient outcomes

A study appearing today in the New England Journal of Medicine adds to the growing body of evidence supporting continuous renal replacement therapy (CRRT) as the therapy of choice for treatment of acute kidney injury (AKI) patients in the intensive care unit (ICU).

23 Oct 2009

Vidacare to release results of validation study on its OnControl Bone Marrow System

Vidacare Corporation has completed an analysis and is releasing the results of a validation study on its OnControl™ Bone Marrow System, the first effort in decades to improve the safety, control, and comfort of bone marrow aspiration and biopsy procedures.

23 Oct 2009

Number of diabetic patients on the rise; figures could reach to 440 million by 2030

Newly published data from the International Diabetes Federation (IDF) show that number of people with diabetes continues to grow unchecked. The figures reveal that, if action is not taken to change the path of the epidemic, the numbers of people with diabetes will be close to 440 million by 2030.

23 Oct 2009

Texas and U.S. homecare groups praise bipartisan bill; say bidding program may reduce quality patient care

The Texas Alliance for Home Care Services and the American Association for Homecare praised a bipartisan bill in Congress, H.R. 3790, to eliminate the deeply flawed "competitive" bidding program for durable medical equipment and services in Medicare.

23 Oct 2009

Decision Resources predicts TNF-alpha inhibitors to dominate rheumatoid arthritis treatment

Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that tumor necrosis factor (TNF)-alpha inhibitors will continue to dominate first- and second-line biologic therapy for the treatment of rheumatoid arthritis in the United States through 2011, but the more established branded drugs such as, Centocor Ortho Biotech's Remicade, Abbott's Humira and Amgen/Wyeth's Enbrel, in this class will face competition from newer entrants.

23 Oct 2009

Community based initiative to help combat obesity and promote healthy lifestyles

President Bill Clinton made a special appearance on October 10 to open the Weight Watchers Presents Fun and Fit in the City -- at the Harlem Children's Zone in Harlem, NY. Part of the Food Network New York City Wine & Food Festival, the free community based initiative -- which drew over 800 attendees -- was created to help combat obesity and provide practical tips for families to follow healthier lifestyles.

23 Oct 2009

Sinovac Biotech to distribute PANFLU.1 vaccine in Mexico

Sinovac Biotech Ltd. (NYSE Amex: SVA), a leading developer and provider of vaccines in China, today announced that it has received a Certificate of Approval from the Secretaria de Salud to distribute PANFLU.1, its H1N1 pandemic influenza (swine flu) vaccine, in Mexico. The certificate is valid through October 13, 2014.

23 Oct 2009

UC Riverside researchers create stable "abnormal N-heterocyclic carbenes"

Researchers at the University of California, Riverside have successfully created in the laboratory a class of carbenes, highly reactive molecules, used to make catalysts - substances that facilitate chemical reactions. Until now, chemists believed these carbenes, called "abnormal N-heterocyclic carbenes" or aNHCs, were impossible to make.

23 Oct 2009

Medical News

Exposing pregnant women to chemotherapy does not affect the foetus

RemedyMD set to deliver 100 specialized disease registry software

Wyle awarded an additional year on its Occupational Medicine and Occupational Health contract supporting NASA

Key tracking measures of public support for health care reform held steady in October

AFGE praises Obama for signing Veterans Health Care Budget Reform and Transparency Act

Quality of U.S. health care was virtually stagnant in 2008, says NCQA report

New technique developed to transform regular body cells into artificial stem cells

Boehringer Ingelheim receives European CHMP positive opinion for MICARDIS

Methyl-Seq and Ultra-Deep Resequencing applications from RainDance Technologies

Archexin has potential to target and treat multiple life-threatening cancers, finds new study

Verizon Foundation awards $10,000 grant to The Wellness Community of the East Bay

Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals start Phase 3 trial to evaluate Nexavar tablets

Study shows appropriate use of CRRT improves AKI patient outcomes

Vidacare to release results of validation study on its OnControl Bone Marrow System

Number of diabetic patients on the rise; figures could reach to 440 million by 2030

Texas and U.S. homecare groups praise bipartisan bill; say bidding program may reduce quality patient care

Decision Resources predicts TNF-alpha inhibitors to dominate rheumatoid arthritis treatment

Community based initiative to help combat obesity and promote healthy lifestyles

Sinovac Biotech to distribute PANFLU.1 vaccine in Mexico

UC Riverside researchers create stable "abnormal N-heterocyclic carbenes"

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News